INS and cancer: In contrast, surgery was associated with a substantially lower rate of mortality from female-specific cancers in the highest insulin third (HRadj = 0.37; 95% CI [0.16, 0.85]; p = 0.019), with evidence of heterogeneity by insulin level (adjusted treatment–insulin interaction p = 0.039) (Fig 4C).